340 related articles for article (PubMed ID: 23800901)
1. Population pharmacokinetics and dosing simulations of amoxicillin/clavulanic acid in critically ill patients.
Carlier M; Noë M; De Waele JJ; Stove V; Verstraete AG; Lipman J; Roberts JA
J Antimicrob Chemother; 2013 Nov; 68(11):2600-8. PubMed ID: 23800901
[TBL] [Abstract][Full Text] [Related]
2. Population pharmacokinetics and dosing simulations of cefuroxime in critically ill patients: non-standard dosing approaches are required to achieve therapeutic exposures.
Carlier M; Noë M; Roberts JA; Stove V; Verstraete AG; Lipman J; De Waele JJ
J Antimicrob Chemother; 2014 Oct; 69(10):2797-803. PubMed ID: 24917580
[TBL] [Abstract][Full Text] [Related]
3. Augmented renal clearance implies a need for increased amoxicillin-clavulanic acid dosing in critically ill children.
De Cock PA; Standing JF; Barker CI; de Jaeger A; Dhont E; Carlier M; Verstraete AG; Delanghe JR; Robays H; De Paepe P
Antimicrob Agents Chemother; 2015 Nov; 59(11):7027-35. PubMed ID: 26349821
[TBL] [Abstract][Full Text] [Related]
4. Non-linear absorption pharmacokinetics of amoxicillin: consequences for dosing regimens and clinical breakpoints.
de Velde F; de Winter BC; Koch BC; van Gelder T; Mouton JW;
J Antimicrob Chemother; 2016 Oct; 71(10):2909-17. PubMed ID: 27330071
[TBL] [Abstract][Full Text] [Related]
5. Impact of high-flux haemodialysis on the probability of target attainment for oral amoxicillin/clavulanic acid combination therapy.
Hui K; Patel K; Kong DCM; Kirkpatrick CMJ
Int J Antimicrob Agents; 2017 Jul; 50(1):110-113. PubMed ID: 28502697
[TBL] [Abstract][Full Text] [Related]
6. Highly variable absorption of clavulanic acid during the day: a population pharmacokinetic analysis.
De Velde F; De Winter BCM; Koch BCP; Van Gelder T; Mouton JW;
J Antimicrob Chemother; 2018 Feb; 73(2):469-476. PubMed ID: 29136160
[TBL] [Abstract][Full Text] [Related]
7. Population pharmacokinetics and dose simulation of vancomycin in critically ill patients during high-volume haemofiltration.
Escobar L; Andresen M; Downey P; Gai MN; Regueira T; Bórquez T; Lipman J; Roberts JA
Int J Antimicrob Agents; 2014 Aug; 44(2):163-7. PubMed ID: 24837847
[TBL] [Abstract][Full Text] [Related]
8. Comparative in vitro activity of a pharmacokinetically enhanced oral formulation of amoxicillin/clavulanic acid (2000/125 mg twice daily) against 9172 respiratory isolates collected worldwide in 2000.
Koeth LM; Jacobs MR; Good CE; Bajaksouzian S; Windau A; Jakielaszek C; Saunders KA
Int J Infect Dis; 2004 Nov; 8(6):362-73. PubMed ID: 15494258
[TBL] [Abstract][Full Text] [Related]
9. Optimal doripenem dosing simulations in critically ill nosocomial pneumonia patients with obesity, augmented renal clearance, and decreased bacterial susceptibility.
Roberts JA; Lipman J
Crit Care Med; 2013 Feb; 41(2):489-95. PubMed ID: 23263583
[TBL] [Abstract][Full Text] [Related]
10. Is the standard dose of amoxicillin-clavulanic acid sufficient?
Haeseker M; Havenith T; Stolk L; Neef C; Bruggeman C; Verbon A
BMC Pharmacol Toxicol; 2014 Jul; 15():38. PubMed ID: 25047044
[TBL] [Abstract][Full Text] [Related]
11. Population pharmacokinetics and pharmacodynamics of continuous versus short-term infusion of imipenem-cilastatin in critically ill patients in a randomized, controlled trial.
Sakka SG; Glauner AK; Bulitta JB; Kinzig-Schippers M; Pfister W; Drusano GL; Sörgel F
Antimicrob Agents Chemother; 2007 Sep; 51(9):3304-10. PubMed ID: 17620371
[TBL] [Abstract][Full Text] [Related]
12. [Sinusal penetration of amoxicillin-clavulanic acid. Formulation 1 g./125 mg., twice daily versus formulation 500 mg./125 mg., three times daily].
Jehl F; Klossek JM; Peynegre R; Serrano E; Castillo L; Bobin S; Desprez D; Renault C; Neel V; Rouffiac E; Borie C
Presse Med; 2002 Oct; 31(34):1596-603. PubMed ID: 12426976
[TBL] [Abstract][Full Text] [Related]
13. Population pharmacokinetics of intravenous polymyxin B in critically ill patients: implications for selection of dosage regimens.
Sandri AM; Landersdorfer CB; Jacob J; Boniatti MM; Dalarosa MG; Falci DR; Behle TF; Bordinhão RC; Wang J; Forrest A; Nation RL; Li J; Zavascki AP
Clin Infect Dis; 2013 Aug; 57(4):524-31. PubMed ID: 23697744
[TBL] [Abstract][Full Text] [Related]
14. Population pharmacokinetics and pharmacodynamic evaluation of intravenous and enteral moxifloxacin in surgical intensive care unit patients.
Kees MG; Schaeftlein A; Haeberle HA; Kees F; Kloft C; Heininger A
J Antimicrob Chemother; 2013 Jun; 68(6):1331-7. PubMed ID: 23463212
[TBL] [Abstract][Full Text] [Related]
15. Population Pharmacokinetic Model-Based Evaluation of Standard Dosing Regimens for Cefuroxime Used in Coronary Artery Bypass Graft Surgery with Cardiopulmonary Bypass.
Alqahtani SA; Alsultan AS; Alqattan HM; Eldemerdash A; Albacker TB
Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29358296
[TBL] [Abstract][Full Text] [Related]
16. Doripenem population pharmacokinetics and dosing requirements for critically ill patients receiving continuous venovenous haemodiafiltration.
Roberts JA; Udy AA; Bulitta JB; Stuart J; Jarrett P; Starr T; Lassig-Smith M; Roberts NA; Dunlop R; Hayashi Y; Wallis SC; Lipman J
J Antimicrob Chemother; 2014 Sep; 69(9):2508-16. PubMed ID: 24879665
[TBL] [Abstract][Full Text] [Related]
17. Population pharmacokinetics and dosing simulations of amoxicillin in obese adults receiving co-amoxiclav.
Mellon G; Hammas K; Burdet C; Duval X; Carette C; El-Helali N; Massias L; Mentré F; Czernichow S; Crémieux AC
J Antimicrob Chemother; 2020 Dec; 75(12):3611-3618. PubMed ID: 32888018
[TBL] [Abstract][Full Text] [Related]
18. Disposition and oral bioavailability of amoxicillin and clavulanic acid in pigs.
Reyns T; De Boever S; Baert K; Croubels S; Schauvliege S; Gasthuys F; De Backer P
J Vet Pharmacol Ther; 2007 Dec; 30(6):550-5. PubMed ID: 17991223
[TBL] [Abstract][Full Text] [Related]
19. First-dose and steady-state population pharmacokinetics and pharmacodynamics of piperacillin by continuous or intermittent dosing in critically ill patients with sepsis.
Roberts JA; Kirkpatrick CM; Roberts MS; Dalley AJ; Lipman J
Int J Antimicrob Agents; 2010 Feb; 35(2):156-63. PubMed ID: 20018492
[TBL] [Abstract][Full Text] [Related]
20. influence of TEM-1 beta-lactamase on the pharmacodynamic activity of simulated total versus free-drug serum concentrations of cefditoren (400 milligrams) versus amoxicillin-clavulanic acid (2,000/125 milligrams) against Haemophilus influenzae strains exhibiting an N526K mutation in the ftsI gene.
Torrico M; Aguilar L; González N; Giménez MJ; Echeverría O; Cafini F; Sevillano D; Alou L; Coronel P; Prieto J
Antimicrob Agents Chemother; 2007 Oct; 51(10):3699-706. PubMed ID: 17664320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
